Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0KCC stock hub

LON/0KCC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0KCCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

118.3M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0KCC

In the news

Latest news · LON/0KCC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROICn/a

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0KCC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

USD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	57
Employees Change	9%
Employees Change Percent	18.37
Enterprise value	$112.3M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US68235C2061
Last refreshed	2026-05-10
Market cap	$118.3M
Price	$4.95
Price currency	USD
Rev Per Employee	52,857.28x
Sector	Healthcare
Sic	2836
Symbol	lon/0KCC
Website	https://www.imdxinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-31.55%
EV Earnings	-3.01x
EV/EBITDA	0.5x
EV/FCF	-5.96x
EV/Sales	37.75x
FCF yield	-15.94%
P/B ratio	-5.06x
P/S ratio	39.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	56.84%
Gross Profit	$1.7M
Gross Profit Growth	178.38%
Gross Profit Growth Q	-19.61%
Gross Profit Growth3 Y	209.17%
Net Income	$-37.3M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-1,238.52%
Profit Per Employee	$-654,648
ROA	-62.66
Roa5y	-26.54
ROCE	-222.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	70.75%
Cagr3y	-2.12%
Cagr5y	-44.17%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth	115.58x
Revenue Growth Q	-23.35x
Revenue Growth Years	3x
Revenue Growth3 Y	61.76x
Revenue Growth5 Y	27.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.13
Assets	$19.1M
Cash	$8.6M
Current Assets	$11.2M
Current Liabilities	$8.9M
Debt	$2.6M
Debt EBITDA	$0.01
Debt FCF	$-0.14
Equity	$-23.4M
Interest Coverage	-279.8
Liabilities	$42.5M
Long Term Assets	$7.9M
Long Term Liabilities	$33.7M
Net Cash	$6M
Net Cash By Market Cap	$5.08
Net Cash Growth	62.63%
Tangible Book Value	$-23.4M
Tangible Book Value Per Share	$-0.82
WACC	12.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Inventory Turnover	4.09
Net Working Capital	$-4.9M
Quick ratio	1.05
Working Capital	$2.4M
Working Capital Turnover	$0.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-133.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	70.69%
200-day SMA	3.79
3Y total return	-6.24%
50-day SMA	4.27
50-day SMA vs 200-day SMA	50over200
5Y total return	-94.57%
All Time High	127.4
All Time High Change	-96.11%
All Time High Date	2021-02-19
All Time Low	1.92
All Time Low Change	158.19%
All Time Low Date	2025-01-22
ATR	0.51
Beta	1.63
Ch YTD	-31.13
High	4.98
High52	7.77
High52 Date	2025-11-14
High52ch	-36.27%
Low	4.72
Low52	2.43
Low52 Date	2025-08-21
Low52ch	104.21%
Ma50ch	15.86%
Price vs 200-day SMA	30.8%
RSI	60.76
RSI Monthly	47.7
RSI Weekly	45.26
Sharpe ratio	0.26x
Sortino ratio	0.44
Total Return	-133.16%
Tr YTD	-31.13
Tr1m	59.74%
Tr1w	20.78%
Tr3m	-29.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-22.7M
Operating margin	-752

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,963,854%
Net Borrowing	-374,092.1
Shares Insiders	12.25%
Shares Institutions	8.71%
Shares Qo Q	0.1%
Shares Yo Y	133.16%
Short Ratio	1.57

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-20.6M
Average Volume	13,696.1x
Bv Per Share	-0.82
CAPEX	$-2.4M
Ch1m	59.74
Ch1w	20.78
Ch1y	70.7
Ch3m	-29.36
Ch3y	-6.25
Ch5y	-94.57
Ch6m	-16.35
Change	1.27%
Change From Open	-0.56
Close	4.89
Days Gap	1.84
Depreciation Amortization	1,611,530.3
Dollar Volume	6,913
Earnings Date	2026-05-13
EBIT	$-22.7M
EBITDA	$-21M
EPS	$-1.22
F Score	3
FCF	$-18.8M
FCF EV Yield	-16.78x
Financing CF	20,857,496
Fiscal Year End	December
Founded	2,009
Investing CF	-2,366,455
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Date	2023-07-25
Last Split Type	Reverse
Ma150	4.13
Ma150ch	19.85%
Ma20	3.99
Ma20ch	24.27%
Net CF	1,919,169
Next Earnings Date	2026-05-13
Open	4.98
Position In Range	89.23
Ppne	6,785,004.5
Price Date	2026-05-08
Relative Volume	0.1x
Revenue	3,012,865x
SBC By Revenue	58.77x
Share Based Comp	1,770,569
Tr6m	-16.35%
Volume	1,396
Z Score	-24.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0KCC pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0KCC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0KCC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.7%

Share of float held by funds and institutions

Insider ownership

+12.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0KCC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.8

Neutral momentum band

Price vs 200-day MA

+30.8%

50/200-day relationship not available

Beta (5Y)

1.63

More volatile than the market

Sharpe ratio

0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0KCC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0KCC stock rating?

lon/0KCC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0KCC analysis?

The full report lives at /stocks/lon/0KCC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0KCC?

The latest report frames lon/0KCC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0KCC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.